Session 222: Optimizing PK/PD of New Antibiotics Against MDR Organisms
The IDWeek 2019 Digital Library is intended as a resource to view IDWeek sessions virtually and claim CME credit. If you plan to claim CME credit for a session, please ensure you have first watched the session video in the DIGITAL LIBRARY prior to completing the evaluation form.
Faculty and Disclosures
Vincent Tam, PharmD; Professor University of Houston, COI Disclosures: Nothing to disclose
Elizabeth Hirsch, PharmD; Assistant Professor, University of Minnesota, COI Disclosures: "Merck: Grant/Research Support, Research Grant, Nabriva Therapeutics: Advisory Board, Paratek Pharmaceuticals: Advisory Board"
Alexander Lepak, MD; Assistant Professor, University of Wisconsin, COI Disclosures: "Paratek Pharmaceuticals: Research Grant, Tetraphase Pharmaceuticals: Research Grant"
Marc Scheetz, PharmD, MSc; Professor of Pharmacy and Pharmacology; Director, Pharmacometrics Center of Excellence, Midwestern University/Northwestern Memorial Hospital, COI Disclosures: "Allecra: Grant/Research Support, Merck, Sharpe, and Dohme: Grant/Research Support, Nevakar: Grant/Research Support"
Kamilia Abdelraouf, PhD; Associate Director,Center for Anti-Infective Research and Development/Hartford Hospital, COI Disclosures: Nothing to disclose
IDSA is accredited by the Accreditation Council for Continuing Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
IDSA designates this enduring material for a maximum of 25.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.25 AMA PRA Category 1 Credit(s)™